Approximately 24,468 bottles of Virbac Animal Health Soloxine (levothyroxine sodium) prescription tablets are being recalled because specific product lots failed to meet established quality specifications. The recall affects 0.2 mg, 0.3 mg, and 0.6 mg strengths in both 250-count and 1,000-count bottle sizes. Because the medication did not meet required standards, it may not provide the precise dosage intended for the animal's thyroid treatment. Owners of pets using this medication should contact their veterinarian or pharmacist for guidance and to obtain a replacement from a non-affected lot.
The product failed to meet established specifications, which could result in the medication being over-potent or under-potent. This may lead to ineffective treatment of hypothyroidism or potential toxicity in pets if the dose is higher than specified.
Refund and replacement of medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response